Phillip Broadwith
As Business editor, my aim is to highlight to readers the exciting and innovative chemistry going on in the commercial sector, as well as keeping you abreast of trends and developments in the world of chemistry businesses.
From the point I left school, my aim was to join the pharmaceutical industry. A gap year and summer placements in company labs, and a PhD in organic synthesis followed.
But halfway through my PhD I entered a writing competition run by the Daily Telegraph. I managed to win – somewhat to my own surprise. That changed my perspective and made me think that I should consider writing more seriously as a career. I joined the Royal Society of Chemistry just before submitting my thesis, and luckily a position with Chemistry World came up a few months later. I sometimes miss the thrills (less so the spills) of lab work, but interacting with world-leading scientists and industrialists, as well as learning new things on a daily basis more than makes up for it.
Contact info
- Email:
- broadwithp@rsc.org
- Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
- Opinion
Will Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
- Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
- Opinion
Get with the quantum program
Now is the time for industry to engage with the emerging world of quantum computers
- Opinion
Is Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
- Business
At least six dead in explosions in US and Russia
Blasts at silicones and fertiliser plants each leave three confirmed dead
- Opinion
Show me the data
Making industrial safety research more transparent benefits both companies and consumers
- Business
Deadly explosion at US chemical plant
Isobutylene tank explosion kills one and hospitalises two at KMCO plant in Crosby
- Business
What might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
- Opinion
Divergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
- Opinion
Thinking differently about waste
Plastic and carbon emissions are valuable resources we can’t afford to discard
- Review
Organic Chemistry for Babies
A chance for parents to start training the next generation of chemists
- Opinion
Pushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
- Opinion
Passing through checkpoints
A new breed of cancer treatments highlights what’s possible when industry concentrates its efforts
- Opinion
Has Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
